Table 4 Baseline characteristics among adults in intensive care unit
Total | Intralipid* | 4-OLE | p value | |
|---|---|---|---|---|
(N = 447) | (N = 110) | (N = 337) | ||
Age (in years), median (IQR) | 61.0 (47.0–70.0) | 60.0 (48.0–72.0) | 61.0 (46.0–69.0) | 0.59 |
Male | 255 (57.0%) | 61 (55.5%) | 194 (57.6%) | 0.7 |
Race | ||||
Caucasian/white | 275 (61.5%) | 72 (65.5%) | 203 (60.2%) | 0.09 |
Black or African-American | 127 (28.4%) | 33 (30.0%) | 94 (27.9%) | |
Other | 45 (10.1%) | 5 (4.5%) | 40 (11.9%) | |
Hispanic | 13 (2.9%) | 0 (0.0%) | 13 (3.9%) | 0.045 |
Payor | ||||
MCO | 126 (28.2%) | 29 (26.4%) | 97 (28.8%) | 0.77 |
Medicaid | 37 (8.3%) | 7 (6.4%) | 30 (8.9%) | |
Medicare | 227 (50.8%) | 59 (53.6%) | 168 (49.9%) | |
Other | 57 (12.8%) | 15 (13.6%) | 42 (12.5%) | |
Comorbidity at admission | ||||
Malnutrition | 327 (73.2%) | 88 (80.0%) | 239 (70.9%) | 0.06 |
Congestive heart failure | 56 (12.5%) | 18 (16.4%) | 38 (11.3%) | 0.16 |
Cancer | 86 (19.2%) | 28 (25.5%) | 58 (17.2%) | 0.06 |
Chronic pulmonary disease | 72 (16.1%) | 23 (20.9%) | 49 (14.5%) | 0.11 |
Liver disease | 49 (11.0%) | 18 (16.4%) | 31 (9.2%) | 0.03 |
Renal failure | 76 (17.0%) | 32 (29.1%) | 44 (13.1%) | < 0.001 |
Diabetes mellitus | 88 (19.7%) | 27 (24.5%) | 61 (18.1%) | 0.14 |
Body weight, kg, median (IQR) | 77.8 (61.4–98.6) | 75.8 (63.0–91.4) | 76.2 (62.5–91.9) | 0.74 |
BMI (kg/m2), median (IQR) | 26.8 (22.1–30.9) | 26.9 (21.8–31.3) | 26.6 (22.2–30.9) | 0.83 |
ED admission | 181 (40.5%) | 36 (32.7%) | 145 (43.0%) | 0.06 |
Mechanical ventilation | 223 (49.9%) | 59 (53.6%) | 164 (48.7%) | 0.37 |
Antibiotic use | 444 (99.3%) | 110 (100.0%) | 334 (99.1%) | 1 |
Use of insulin | 294 (65.8%) | 81 (73.6%) | 213 (63.2%) | 0.045 |
Use of statin | 106 (23.7%) | 18 (16.4%) | 88 (26.1%) | 0.037 |